Greystone Associates

Report: Device technology shaping delivery of new therapeutics

Published in Health Insurance Law Weekly, May 1st, 2005

Aging population demographics and managed care initiatives are major forces driving the future direction of healthcare, a trend that includes the self-administration of drug therapies for chronic conditions such as diabetes, arthritis, hormone replacement therapy, and a growing list of treatments.

This trend is creating an increased interest in routes of administration that are patient-friendly and cost-effective.

A significant number of new therapeutic compounds winding their way through development and clinical trials - particularly protein and peptide-based drugs - are being formulated for injection. To address these market forces, a growing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly

Source: Health Insurance Law Weekly (2005-05-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry